Sanofi SA SASY.PA:
* SANOFI INVESTS MORE THAN ONE BILLION ADDITIONAL EUROS IN THE PRODUCTION OF MEDICINES IN FRANCE, IN ADDITION TO THE 2.5 BILLION EUROS ALREADY COMMITTED TO MAJOR HEALTH SOVEREIGNTY PROJECTS
* SANOFI INCREASES ITS INVESTMENTS IN ITS MAJOR INDUSTRIAL PROJECTS BY 1.1 BILLION EUROS
* TO CREATE NEW BIOPRODUCTION CAPACITIES AT ITS VITRY-SUR-SEINE (VAL DE MARNE), LE TRAIT (SEINE-MARITIME) AND LYON GERLAND (RHÔNE) SITES
* DEPLOYS AN INVESTMENT PLAN OF MORE THAN 3.5 BILLION EUROS TO FINANCE ITS MAJOR DRUG AND VACCINE PRODUCTION PROJECTS IN FRANCE
* IN 2023, THANKS TO THIS INDUSTRIAL FOOTPRINT, SANOFI’S CONTRIBUTION TO FRANCE’S TRADE BALANCE AMOUNTED TO MORE THAN 13 BILLION EUROS
Original text on Workspace ID:nGNE2l6l5K For more details, click SASY.PA
(Gdansk editorial office)